NYSE - Delayed Quote USD

McKesson Corporation (MCK)

524.83 +6.02 (+1.16%)
At close: April 19 at 4:00 PM EDT
524.99 +0.16 (+0.03%)
After hours: April 19 at 7:06 PM EDT

Earnings Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 15101818
Avg. Estimate 6.347.1527.631.01
Low Estimate 6.26.8427.3130.07
High Estimate 6.687.2927.9331.6
Year Ago EPS 7.197.2725.9427.6

Revenue Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 1271515
Avg. Estimate 79.35B80.84B311.94B337.77B
Low Estimate 77.7B78.17B310.3B332.67B
High Estimate 81.12B82.67B313.71B348.95B
Year Ago Sales 68.91B--276.71B311.94B
Sales Growth (year/est) 15.10%--12.70%8.30%

Earnings History

CURRENCY IN USD 3/31/2023 6/30/2023 9/30/2023 12/31/2023
EPS Est. 7.175.876.157.05
EPS Actual 7.197.276.237.74
Difference 0.021.40.080.69
Surprise % 0.30%23.90%1.30%9.80%

EPS Trend

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate 6.347.1527.631.01
7 Days Ago 6.347.1527.631.01
30 Days Ago 6.357.1327.6131.01
60 Days Ago 6.357.1527.6131
90 Days Ago 6.777.2527.3130.79

EPS Revisions

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --124
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD MCKIndustrySectorS&P 500
Current Qtr. -11.80%----1.60%
Next Qtr. -1.70%----10.50%
Current Year 6.40%----5.20%
Next Year 12.40%----13.30%
Next 5 Years (per annum) 10.61%----11.22%
Past 5 Years (per annum) 18.33%------

Research Analysis

Analyst Price Targets

502.00 Low
569.22 Average
524.83 Current
620.00 High

Fair Value

Overvalued
% Return
524.83 Current
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Upgrades & Downgrades

Maintains Morgan Stanley: Overweight to Overweight 4/15/2024
Maintains Argus Research: Buy to Buy 4/10/2024
Maintains UBS: Buy to Buy 3/6/2024
Initiated Leerink Partners: Outperform 2/26/2024
Maintains Mizuho: Neutral to Neutral 2/9/2024
Maintains Citigroup: Buy to Buy 2/8/2024

Related Tickers